Coronary patients with high plasma omentin are at a higher cardiovascular risk
Open Access
- 1 March 2016
- journal article
- Published by Elsevier in Data in Brief
- Vol. 6, 158-161
Abstract
No abstract availableKeywords
Funding Information
- Austrian National Bank (14159)
- Dr. Karl Josef Hier and the Peter Goop Stiftung
- Fachhochschule Dornbirn
- Institute for Clinical Chemistry at the Academic Teaching Hospital Feldkirch
This publication has 7 references indexed in Scilit:
- High plasma omentin predicts cardiovascular events independently from the presence and extent of angiographically determined atherosclerosisAtherosclerosis, 2016
- Examination of angiopoietin-like protein 4, neuropeptide Y, omentin-1 levels of obese and non-obese patients with polycystic ovary syndromeGynecological Endocrinology, 2015
- Serum levels of novel adipokines, omentin-1 and chemerin, in patients with acute myocardial infarctionJournal of Cardiovascular Medicine, 2015
- Decreased Levels of Serum Omentin-1 in Patients with Inflammatory Bowel DiseaseMedical Science Monitor, 2015
- Relationships between serum omentin-1, body fat mass and bone mineral density in healthy Chinese male adults in Changsha areaJournal of Endocrinological Investigation, 2014
- Changes of Serum Omentin Levels and Relationship between Omentin and Adiponectin Concentrations in Type 2 Diabetes MellitusExperimental and Clinical Endocrinology & Diabetes, 2011
- Metformin Treatment May Increase Omentin-1 Levels in Women With Polycystic Ovary SyndromeDiabetes, 2010